These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

932 related articles for article (PubMed ID: 21290442)

  • 21. Salicylic acid in ginseng root alleviates skin hyperpigmentation disorders by inhibiting melanogenesis and melanosome transport.
    Liu J; Jiang R; Zhou J; Xu X; Sun Z; Li J; Chen X; Li Z; Yan X; Zhao D; Zheng Z; Sun L
    Eur J Pharmacol; 2021 Nov; 910():174458. PubMed ID: 34480884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tyrosine levels regulate the melanogenic response to alpha-melanocyte-stimulating hormone in human melanocytes: implications for pigmentation and proliferation.
    Schwahn DJ; Xu W; Herrin AB; Bales ES; Medrano EE
    Pigment Cell Res; 2001 Feb; 14(1):32-9. PubMed ID: 11277492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new role for epidermal cell-derived thymocyte activating factor/IL-1 as an antagonist for distinct epidermal cell function.
    Swope VB; Abdel-Malek ZA; Sauder DN; Nordlund JJ
    J Immunol; 1989 Mar; 142(6):1943-9. PubMed ID: 2466081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-carboline alkaloids harmaline and harmalol induce melanogenesis through p38 mitogen-activated protein kinase in B16F10 mouse melanoma cells.
    Park SY; Kim YH; Kim YH; Park G; Lee SJ
    BMB Rep; 2010 Dec; 43(12):824-9. PubMed ID: 21189160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plumbagin Suppresses α-MSH-Induced Melanogenesis in B16F10 Mouse Melanoma Cells by Inhibiting Tyrosinase Activity.
    Oh TI; Yun JM; Park EJ; Kim YS; Lee YM; Lim JH
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28165370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An inhibitory mechanism of action of a novel syringic-acid derivative on α-melanocyte-stimulating hormone (α-MSH)-induced melanogenesis.
    Jeong YJ; Lee JY; Park J; Park SN
    Life Sci; 2017 Dec; 191():52-58. PubMed ID: 28993145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycine hydroxamate inhibits tyrosinase activity and melanin contents through downregulating cAMP/PKA signaling pathways.
    Lin YS; Wu WC; Lin SY; Hou WC
    Amino Acids; 2015 Mar; 47(3):617-25. PubMed ID: 25501504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uveal melanocytes do not respond to or express receptors for alpha-melanocyte-stimulating hormone.
    Li L; Hu DN; Zhao H; McCormick SA; Nordlund JJ; Boissy RE
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4507-12. PubMed ID: 17003446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered N-glycosylation in macrophage x melanoma fusion hybrids.
    Pawelek JM; Chakraborty AK; Rachkovsky ML; Orlow SJ; Bolognia JL; Sodi SA
    Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):1011-27. PubMed ID: 10644005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aglycone of Rh4 inhibits melanin synthesis in B16 melanoma cells: possible involvement of the protein kinase A pathway.
    Jeong YM; Oh WK; Tran TL; Kim WK; Sung SH; Bae K; Lee S; Sung JH
    Biosci Biotechnol Biochem; 2013; 77(1):119-25. PubMed ID: 23291754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ov-16 [4-(3,4-dihydroxybenzoyloxymethyl)phenyl-O-β-D-glucopyranoside] inhibits melanin synthesis by regulating expressions of melanogenesis-regulated gene and protein.
    Liang CH
    Exp Dermatol; 2011 Sep; 20(9):743-8. PubMed ID: 21672031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melanin Inhibitory Effect of
    Choi BM; Kim M; Hong H; Park TJ; Kim C; Park JS; Chi WJ; Kim SY
    J Microbiol Biotechnol; 2024 Apr; 34(4):949-957. PubMed ID: 38480002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Agouti signaling protein inhibits melanogenesis and the response of human melanocytes to alpha-melanotropin.
    Suzuki I; Tada A; Ollmann MM; Barsh GS; Im S; Lamoreux ML; Hearing VJ; Nordlund JJ; Abdel-Malek ZA
    J Invest Dermatol; 1997 Jun; 108(6):838-42. PubMed ID: 9182807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dioscin Derived from Solanum melongena L. "Usukawamarunasu" Attenuates α-MSH-Induced Melanogenesis in B16 Murine Melanoma Cells via Downregulation of Phospho-CREB and MITF.
    Nishina A; Ebina K; Ukiya M; Fukatsu M; Koketsu M; Ninomiya M; Sato D; Kimura H
    J Food Sci; 2015 Oct; 80(10):H2354-9. PubMed ID: 26352003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of melanogenesis induced by 5-methoxypsoralen without ultraviolet light in murine melanoma cells.
    Mengeaud V; Ortonne JP
    Pigment Cell Res; 1994 Aug; 7(4):245-54. PubMed ID: 7855073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melatonin antagonizes alpha-melanocyte-stimulating hormone enhancement of melanogenesis in mouse melanoma cells by blocking the hormone-induced accumulation of the c locus tyrosinase.
    Valverde P; Benedito E; Solano F; Oaknin S; Lozano JA; García-Borrón JC
    Eur J Biochem; 1995 Aug; 232(1):257-63. PubMed ID: 7556159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acteoside inhibits melanogenesis in B16F10 cells through ERK activation and tyrosinase down-regulation.
    Son YO; Lee SA; Kim SS; Jang YS; Chun JC; Lee JC
    J Pharm Pharmacol; 2011 Oct; 63(10):1309-19. PubMed ID: 21899547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory effects of Asterina pectinifera extracts on melanin biosynthesis through tyrosinase activity.
    Jeong MH; Yang KM; Kim JK; Nam BH; Kim GY; Lee SW; Seo SY; Jo WS
    Int J Mol Med; 2013 Jan; 31(1):205-12. PubMed ID: 23151809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-melanogenesis effect of dehydroglyasperin C through the downregulation of MITF via the reduction of intracellular cAMP and acceleration of ERK activation in B16F1 melanoma cells.
    Lim JW; Ha JH; Jeong YJ; Park SN
    Pharmacol Rep; 2018 Oct; 70(5):930-935. PubMed ID: 30099299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. β-Cryptoxanthin suppresses UVB-induced melanogenesis in mouse: involvement of the inhibition of prostaglandin E2 and melanocyte-stimulating hormone pathways.
    Shimoda H; Shan SJ; Tanaka J; Maoka T
    J Pharm Pharmacol; 2012 Aug; 64(8):1165-76. PubMed ID: 22775220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.